Position in SLXN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$0
+$0 QoQ
Shares Held
100,000
0.0% QoQ
Ownership
1.80%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SLXN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Kepos Capital LP holds $0 across 2 Biotechnology names. SLXN ranks #2 .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KTTA |
Pasithea Therapeutics Corp.
|
334,600 | $0 | |
| 2 | SLXN |
Silexion Therapeutics Corp
This page
|
100,000 | $0 |
All Filings in SLXN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 SLXNW | — | 100,000 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 SLXNW | — | 100,000 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 SLXNW | — | 100,000 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 SLXNW | — | 100,000 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 SLXNW | — | 100,000 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 SLXNW | — | 100,000 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 SLXNW | — | 100,000 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 SLXNW | — | 100,000 | Shares | Sole | 2024-11-12 | |
| No filing history on record for this holder in this stock. | ||||||